Global Launch of ExactechGPS® Gains Early Surgeon Acceptance
September 10 2015 - 12:00PM
Business Wire
Surgeons Gain Hands-On Experience at Exactech’s
First Asia-Pacific Computer-Assisted Surgery Medical Education
Courses
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone
and joint restoration products for hip, knee, shoulder and spine,
reported today that surgeons around the world are expressing
positive response to Exactech’s (Nasdaq: EXAC) international launch
of ExactechGPS® Guided Personalized Surgery, a computer-assisted
technology that provides surgeons with real-time, patient-specific
data to guide their implantation and alignment of Exactech’s
Optetrak Logic® knee system.
This Smart News Release features multimedia.
View the full release here:
http://www.businesswire.com/news/home/20150910006300/en/
ExactechGPS® Guided Personalized Surgery
is a powerful, yet compact advanced surgical technology platform
that delivers efficiency and reproducibility in total joint
replacement. (Photo: Business Wire)
Nearly 40 orthopaedic surgeons from eight countries, including
China, Japan, Singapore, Malaysia, India, U.S., Australia and South
Korea, convened this month for Exactech’s first Asia-Pacific
computer-assisted surgery masters course in Singapore. The event
featured lectures from renowned surgeons and technology thought
leaders, and provided surgeons hands-on cadaveric experience with
the technology. A similar medical education course in Taiwan drew
35 surgeons.
"Accurate surgery leads to better benefit for patients and this
system has a high potential for becoming widely used in Japan,"
said Kentaro Suzuki, MD, head of orthopaedic surgery at Iida
Hospital, Nagao, Japan.
Suzuki is among the growing list of surgeon users around the
world, who are expressing even greater confidence in the proper
placement of implants through use of ExactechGPS. The continued
development of the system follows Exactech’s recent acquisition of
technology partner Blue Ortho, a leading computer-assisted surgery
development and manufacturing firm.
Exactech introduced ExactechGPS® to surgeons in the U.S.
in 2014, and has since broadened its reach by providing medical
education and supporting surgeries in more than 11 countries. The
technology has steadily gained market acceptance and worldwide
reach.
Exactech CEO David Petty said, “Surgeons and hospitals around
the world are recognizing the clinical advantages of using
ExactechGPS® for their knee replacement patients. The
positive response from surgeons in varied parts of the globe is a
testament to the technology’s unmatched capabilities and Exactech’s
commitment to deliver innovative solutions that improve clinical
outcomes.”
About ExactechGPS®
ExactechGPS® Guided Personalized Surgery is a powerful,
yet compact advanced surgical technology platform that delivers
efficiency and reproducibility in total joint replacement. Merging
sophisticated technology with innovative instrumentation,
ExactechGPS delivers a real-time, patient-specific solution
designed for improved clinical outcomes. For more information about
ExactechGPS®, visit www.exactechgps.com.
About Exactech
Based in Gainesville, Fla., Exactech develops and markets
orthopaedic implant devices, related surgical instruments and
biologic materials and services to hospitals and physicians. The
company manufactures many of its orthopaedic devices at its
Gainesville facility. Exactech’s orthopaedic products are used in
the restoration of bones and joints that have deteriorated as a
result of injury or diseases such as arthritis. Exactech markets
its products in the United States, in addition to more than 30
markets in Europe, Latin America, Asia and the Pacific. Additional
information about Exactech, Inc. can be found at
http://www.exac.com. Copies of Exactech’s press releases, SEC
filings, current price quotes and other valuable information for
investors may be found at http://www.exac.com and
http://www.hawkassociates.com.
An investment profile on Exactech may be found at
http://www.hawkassociates.com/profile/exac.cfm. To receive future
releases in e-mail alerts, sign up at
http://www.hawkassociates.com/about/alert.
This release contains various forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934, which represent
the company’s expectations or beliefs concerning future events of
the company’s financial performance. These forward-looking
statements are further qualified by important factors that could
cause actual results to differ materially from those in the
forward-looking statements. These factors include the effect of
competitive pricing, the company’s dependence on the ability of
third party manufacturers to produce components on a basis which is
cost-effective to the company, market acceptance of the company’s
products and the effects of government regulation. Results actually
achieved may differ materially from expected results included in
these statements.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150910006300/en/
Exactech, Inc.Investor contactsJody Phillips,
352-377-1140Executive Vice President of Finance & Chief
Financial OfficerorMedia contactPriscilla Bennett, 352-377-1140Vice
President, Corporate & Marketing CommunicationorHawk
AssociatesJulie Marshall or Frank Hawkins,
305-451-1888EXAC@hawkassociates.com
Exactech, Inc. (delisted) (NASDAQ:EXAC)
Historical Stock Chart
From Feb 2024 to Mar 2024
Exactech, Inc. (delisted) (NASDAQ:EXAC)
Historical Stock Chart
From Mar 2023 to Mar 2024